Scientists have uncovered a promising way to fight prostate cancer by targeting a single enzyme, PI5P4Kα. This discovery ...

Overriding the "Off Switch" Cells function through an intricate network of proteins, each designed for specific tasks like ...

Metabolic cell death represents a rapidly evolving and intricate field within cancer research. Recent studies have elucidated ...

Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, a new study demonstrates how some cancer cells use the protein ...

When experienced researcher Renato Aguilera happened across the chemical structure of a tried-and-true antimalarial drug one ...

There is a trial of strength at the cellular level. Cells are in constant competition with each other and so eliminate ...

This review highlights the critical role of ubiquitin-specific proteases (USPs) in regulating programmed cell death (PCD) in breast cancer (BC). As the most prevalent malignant tumor among women, BC ...

Particularly noteworthy among these compounds are 6-gingerol and 6-shogaol, which have been recognized for their potent ...

St. Jude researchers identified a protein, voltage-dependent anion channel 2 (VDAC2), that tumors use as a “signal jammer” to prevent cancer cell death and evade the immune system’s functioning.

Scientists develop nanoparticles that monitor cancer cell death by detecting potassium release, allowing doctors to optimize ...

The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel ...